Amgen

NCT00869284

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas

NCT00100477

Use of Topotecan in Patients With Refractory Acute Leukemia

NCT03774771

Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism

NCT01016795

Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma

NCT00636909

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

NCT00005958

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

NCT00005960

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00006215

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00936650

A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)

NCT00005959

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

NCT00035620

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

NCT00526929

Fixed Dose NESP Study in Subjects With CRI

NCT03776058

Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)

NCT00037648

Juvenile Rheumatoid Arthritis

NCT00936988

A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

NCT00037700

Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

NCT00537667

The SPECTRA Study

NCT00540696

Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa

NCT00527085

12-month Study of AMG 073 in Renal Osteodystrophy

NCT00050674

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00035607

Chemotherapy Related Anemia

NCT00140244

Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome

NCT00194753

Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

NCT00034346

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00111774

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

NCT00527215

Phase 2 Study of Darbepoetin Alfa Extended Dosing

NCT00038298

A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate

NCT00043186

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

NCT00989092

Darbepoetin Alfa and Anemia of Cancer

NCT00042432

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

NCT00111475

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

NCT00049985

Heart Failure and Anemia

NCT00111761

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

NCT00117897

Treatment for Subjects With Non-Hodgkin's Lymphoma

NCT00111423

Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)

NCT00117442

A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

NCT00079612

Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

NCT00120679

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

NCT00120692

Treatment for Patients Suffering From Anemia Due to Chemotherapy

NCT00121030

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

NCT00110929

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

NCT00120705

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00433875

Phase 2 AMG 714 in Rheumatoid Arthritis

NCT00094809

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

NCT00115193

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

NCT00425035

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

NCT00114764

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

NCT00066092

Pegfilgrastim PBPC Mobilization Study

NCT00193479

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

NCT00245895

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

NCT00101920

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00113945

Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

NCT00086086

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

NCT00072319

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

NCT00682383

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

NCT00113789

Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer

NCT00280787

Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim

NCT00067639

Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma

NCT00083616

Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

NCT00425204

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

NCT00101413

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

NCT00169143

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

NCT00110916

Treatment for Patients With Osteoarthritis (OA) of the Knee

NCT00089635

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

NCT00095498

Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis

NCT00102921

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00594620

Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

NCT00091832

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

NCT00231582

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

NCT00509600

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

NCT00089960

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

NCT00095264

A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome

NCT00095277

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

NCT01502982

Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)

NCT00591851

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

NCT00604682

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

NCT00104650

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

NCT00094861

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00293202

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

NCT00110942

Treatment for Patients With Osteoarthritis (OA)

NCT00110994

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

NCT00240097

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

NCT00121628

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

NCT00144131

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

NCT00239239

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

NCT00254267

Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

NCT00259740

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

NCT00445042

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

NCT00261313

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

NCT00360867

An Open Label Treatment Extension Study of AMG 706

NCT00189488

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

NCT00306189

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

NCT00695370

Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

NCT00303472

Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)

NCT00293826

A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

NCT00306215

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

NCT00606450

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

NCT00327119

Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer

NCT00332163

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

NCT00261950

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease

NCT00293813

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

NCT00508625

A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

NCT00346099

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

NCT00396279

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

NCT00369473

Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

NCT00321711

Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents

NCT00418938

SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial

NCT00411450

Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment

NCT00427440

A Phase II Study to Treat Advanced Malignant Glioma

NCT00356681

A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

NCT00401544

Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00413283

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

NCT00418665

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid

NCT00454779

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

NCT00369070

A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

NCT00422019

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

NCT00613730

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint

NCT00456092

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

NCT00436670

Phase II Study to Evaluate the Efficacy of AMG 317

NCT00443326

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

NCT00456716

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

NCT00508404

Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer

NCT00467025

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

NCT00475293

Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

NCT00493636

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

NCT00499525

Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer

NCT00479817

Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer

NCT00511459

Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients

NCT00521339

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

NCT00511238

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

NCT00530816

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

NCT00500760

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

NCT00446446

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

NCT00540657

A Phase II Study of CCX282-B in Patients With Celiac Disease

NCT00551200

Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders

NCT00632541

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

NCT00547157

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00798655

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

NCT00583674

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

NCT00597909

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

NCT00570999

Palifermin After Haploidentical PBSCT

NCT00530114

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

NCT00661141

Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism

NCT00661921

A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

NCT00677365

Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients

NCT00686335

A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma

NCT00614523

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT00773734

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

NCT00680992

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

NCT00794261

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma

NCT00863460

Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

NCT00756444

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT00739648

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00721734

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

NCT00752570

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

NCT00808639

Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

NCT00757172

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

NCT00639717

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

NCT00841789

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

NCT00865709

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

NCT00884312

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

NCT00819780

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

NCT00853372

AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib

NCT00836277

Phase II Study of Irinotecan and Panitumumab

NCT00842257

Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer

NCT00885885

Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases

NCT00896532

Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

NCT00887965

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

NCT00925821

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

NCT00926380

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis

NCT00915252

Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT00866359

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease

NCT00872014

A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer

NCT00958386

Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)

NCT00907296

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

NCT01144195

A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy

NCT01018550

AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma

NCT00896454

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

NCT00950989

Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate

NCT00999167

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

NCT00940316

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

NCT01028963

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

NCT00894504

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

NCT01017653

Panitumumab and Irinotecan for Malignant Gliomas